In addition, a cohort study which analysed 114 RCC patients samples collected from 1990 to 2005 from the Mayo Clinic Rochester has found that ADAMTS12 together with other ECM components, such as lumican and laminin-2, were upregulated in metastatic tumours compared to primary tumours[77]. The gene discussed is ADAMTS12; the disease is neoplasm.